ClinicalTrials.gg

Program

CEA-targeted CAR-T cells

Its studies are mostly in Stomach Neoplasms · Lung Neoplasms · Colorectal Neoplasms, led by Chongqing Precision Biotech.

Furthest: phase 2, since Sep 9, 20225 company-led studies, 4 open or runningNext primary completion: Dec 31, 2026 (phase 1)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Chongqing Precision Biotech54 open or runningphase 2since Sep 9, 2022Sep 9, 2022Dec 31, 2026phase 1 · NCT06043466

Also a collaborator on its studies: First Affiliated Hospital of Wannan Medical College.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Sep 9, 2022First study: phase 2 study in Stomach NeoplasmsFirst studyNCT05538195 · 17 enrolled · China
  2. Aug 17, 2023Phase 2 study in Stomach NeoplasmsNCT06006390 · 60 planned · China
  3. Sep 5, 2023Phase 1 study in Colorectal NeoplasmsNCT06043466 · 30 planned · China
  4. Nov 6, 2023Phase 1 study in Stomach NeoplasmsNCT06126406 · 60 planned · China
  5. Sep 11, 2025Phase 1 study in Lung NeoplasmsNCT07179692 · 108 planned · China

Ahead

  1. Dec 31, 2026Primary completion: phase 1 study in Colorectal NeoplasmsNCT06043466
  2. Mar 31, 2028Primary completion: phase 1 study in Lung NeoplasmsNCT07179692

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 5 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07179692Lung Neoplasms · China1RecruitingMar 31, 2028108
NCT06126406Stomach Neoplasms · China1RecruitingDec 31, 202560
NCT06043466Colorectal Neoplasms · China1RecruitingDec 31, 202630
NCT06006390Stomach Neoplasms · China2RecruitingDec 31, 202560
NCT05538195Stomach Neoplasms · China2CompletedDec 30, 202317

How it is read

Names in the registry

  • “CEA-targeted CAR-T cells”, 10 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.